This company has been marked as potentially delisted and may not be actively trading. Millendo Therapeutics (MLND) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock MLND vs. SBTX, MBX, AVTE, NLTX, BIOA, ELYM, CYBN, VIRI, WHWK, and OSTXShould you be buying Millendo Therapeutics stock or one of its competitors? The main competitors of Millendo Therapeutics include Silverback Therapeutics (SBTX), MBX Biosciences (MBX), Aerovate Therapeutics (AVTE), Neoleukin Therapeutics (NLTX), BioAge Labs (BIOA), Eliem Therapeutics (ELYM), Cybin (CYBN), Virios Therapeutics (VIRI), Whitehawk Therapeutics (WHWK), and OS Therapies (OSTX). Millendo Therapeutics vs. Its Competitors Silverback Therapeutics MBX Biosciences Aerovate Therapeutics Neoleukin Therapeutics BioAge Labs Eliem Therapeutics Cybin Virios Therapeutics Whitehawk Therapeutics OS Therapies Silverback Therapeutics (NASDAQ:SBTX) and Millendo Therapeutics (NASDAQ:MLND) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and media sentiment. Does the media prefer SBTX or MLND? In the previous week, Silverback Therapeutics had 1 more articles in the media than Millendo Therapeutics. MarketBeat recorded 1 mentions for Silverback Therapeutics and 0 mentions for Millendo Therapeutics. Silverback Therapeutics' average media sentiment score of 0.00 equaled Millendo Therapeutics'average media sentiment score. Company Overall Sentiment Silverback Therapeutics Neutral Millendo Therapeutics Neutral Do institutionals & insiders hold more shares of SBTX or MLND? 74.9% of Silverback Therapeutics shares are owned by institutional investors. 34.4% of Silverback Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is SBTX or MLND more profitable? Silverback Therapeutics' return on equity of -29.62% beat Millendo Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Silverback TherapeuticsN/A -29.62% -28.20% Millendo Therapeutics N/A -91.03%-72.44% Which has more volatility & risk, SBTX or MLND? Silverback Therapeutics has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500. Comparatively, Millendo Therapeutics has a beta of 0.48, indicating that its share price is 52% less volatile than the S&P 500. Which has preferable earnings & valuation, SBTX or MLND? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSilverback TherapeuticsN/AN/A-$89.48M-$2.42-4.14Millendo TherapeuticsN/AN/A-$36.41MN/AN/A SummarySilverback Therapeutics beats Millendo Therapeutics on 6 of the 7 factors compared between the two stocks. Get Millendo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MLND and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MLND and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MLND vs. The Competition Export to ExcelMetricMillendo TherapeuticsPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$195.29M$736.37M$5.84B$10.14BDividend YieldN/A4.84%5.68%4.60%P/E RatioN/A1.1775.4125.98Price / SalesN/A26.64515.81181.13Price / CashN/A19.5637.5660.44Price / Book5.766.6812.156.29Net Income-$36.41M-$4.13M$3.29B$271.07M Millendo Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MLNDMillendo TherapeuticsN/A$10.26-4.2%N/A+607.2%$195.29MN/A0.0012SBTXSilverback TherapeuticsN/A$10.70+6.3%N/A-20.6%$385.82MN/A-4.4283News CoverageHigh Trading VolumeMBXMBX Biosciences2.8336 of 5 stars$11.42+4.8%$37.63+229.5%N/A$366.18MN/A-2.5236News CoveragePositive NewsAVTEAerovate TherapeuticsN/A$7.48-3.7%N/A-88.4%$216.81MN/A-2.5020Positive NewsHigh Trading VolumeNLTXNeoleukin TherapeuticsN/A$19.45-2.5%N/A-54.7%$182.79MN/A-6.2590High Trading VolumeBIOABioAge Labs0.1263 of 5 stars$4.98-2.2%N/AN/A$182.48MN/A0.00N/AELYMEliem TherapeuticsN/A$2.47+3.3%N/A-73.4%$152.03MN/A-4.669News CoverageCYBNCybin2.6914 of 5 stars$6.43+2.6%$85.00+1,221.9%N/A$151.68MN/A-1.4750News CoveragePositive NewsGap DownHigh Trading VolumeVIRIVirios TherapeuticsN/A$4.90flat$5.00+2.0%+2,410.3%$94.36MN/A-18.155WHWKWhitehawk Therapeutics1.1859 of 5 stars$1.80+0.6%N/AN/A$84.36M$25.98M-30.0021OSTXOS Therapies2.074 of 5 stars$2.19-2.2%$18.00+721.9%-34.6%$69.30MN/A-2.77N/AAnalyst Forecast Related Companies and Tools Related Companies SBTX Alternatives MBX Alternatives AVTE Alternatives NLTX Alternatives BIOA Alternatives ELYM Alternatives CYBN Alternatives VIRI Alternatives WHWK Alternatives OSTX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MLND) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 Bitcoin miner reveals his trading system (free)There are 18,347 cryptocurrencies in the market right now. 99% of them will fail. And trying to pick winner...Crypto Swap Profits | SponsoredExpert Alert: Massive Bubble Could Crash Your WealthOn July 4th, Trump signed the “One Big Beautiful Bill,” adding $3.4 trillion to the national debt — and pushin...American Alternative | SponsoredThe End of Elon Musk…?While headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Millendo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Millendo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MLND Stock Alerts